HIGH DOSE ANTIBODY THERAPIES FOR SARS-COV-2 INFECTION Application WO-2023201256-A1 World Intellectual Property Organisation (WIPO) 19 Oct 2023
VIROLOGICAL AND MOLECULAR SURROGATES OF RESPONSE TO SARS-COV-2 NEUTRALIZING ANTIBODY… Application WO-2023086635-A1 World Intellectual Property Organisation (WIPO) 19 May 2023
COMPOSITIONS Application WO-2023084055-A1 World Intellectual Property Organisation (WIPO) 19 May 2023
ANTIBODY THERAPIES FOR SARS-COV-2 INFECTION IN PEDIATRIC SUBJECTS Application WO-2023034866-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023